Max Herzberg, PhD – CEO
Prof. Max Herzberg, the Founder and Chairperson of the Board of Vidac Pharma, is a renowned scientist and entrepreneur and one of the founding fathers of the Israel life sciences industry. Prof. Herzberg founded Orgenics and the EagerBio Group, is the co-founder of PixCell, and served as chairperson of several Israeli biotechnology companies and as chairperson of the European Molecular Biology Laboratory Enterprise Management (Heidelberg, Germany). Prof. Herzberg holds a Ph.D. in Molecular Biology from the Weizmann Institute of Science.
Shuki Cohen – CFO
Shuki Cohen, CPA, has over 30 years of experience specializing in Healthcare companies from seed to IPO. Mr. Cohen has a vast experience in all stages of companies and of all financial aspects. He had served as treasurer as well as active accountant for many biotech companies in Israel.
Sandra Gamzon – Operations Manager
Sandra Gamzon, MBA, has over 25 years of experience in the Biotech and Hi-tech industry as an Operation Manager in various companies, especially seed companies from inception to commercial success.
Gilad Peleg, MBA - Head of Business Development
A seasoned health-tech executive and investor, with a broad experience base of over 30 years, starting with blue chip corporate pharma business development, launching, and managing innovative med-tech start-ups, and finally as a venture capital general partner.
Founding Partner at Neuro1 Capital, a neurotech venture builder operation, Co-Founder at Elda-ai, a company combing EEG & fMRI data for enhanced brain assessment, Co-Founder & General Managing Partner, at Corundum Open Innovation, a top quartile med-tech focused venture capital fund.
Oren Becker, Phd. - Drug Development Senior Advisor
Previous CEO of Vidac Pharma Ltd. (2013-2019). Dr. Becker brings more than 20 years of biopharmaceutical industry entrepreneurship and leadership experience to the Company, with expertise in the discovery and development of innovative novel pharmaceuticals. Dr. Becker was a founder, Director and Chief Science Officer of several Biotech companies. He holds a Ph.D from the Hebrew University of Jerusalem, and a postdoctoral training from Harvard University.
Dr. Galia Temtsin Krayz, Phd. - CMC Formulations Senior Advisor
With a career with over two decades in the Life Science and Pharma Industries, Dr. Temtsin Krayz is a highly respected and recognized expert in these fields. Throughout her career, Dr. Temtsin Krayz has made significant contributions to the industry as an inventor of several proprietary technologies, including SolumerTM-oral, Omexa-transmucosal sub-lingual, and Nasax-intranasal.
Dr. Rakefet Rosenfeld - Science and Technologies Senior Advisor
Dr. Rakefet Rosenfeld – researcher and entrepreneur in the field of biotechnology. Holds a B.Sc. in Biology and Computer Science, and a Ph.D. in Computational Biology. In the past, Research Associate Professor in the Department of Biomedical Engineering at Boston University, and has more than 20 years of experience in the development of technologies and medicine in the Israeli Biotech Industry.
Dr. Tami Rachmilewitz - Clinical affairs Senior Advisor
Dr. Tami Rachmilewitz is a clinical research physician executive with over 20 years of experience in the Pharmaceutical Industry. She held Medical leadership roles in VBL Therapeutics, Neuroderm, Teva & Novartis, where she led early and late phase clinical development programs in Oncology, Neurology and Immunology. She holds an MD from the Medical School at the Hebrew University in Jerusalem, and trained in Psychiatry at the Hadassah Medical Center in Jerusalem.
Natalia Kronik, Adv. - Company Secretary
Natalia has over 10 year of experience in corporate law, structuring deals, financial legal advice on transactions working at BIG 4 audit firm. Natalia was recently involved in borrowing deals and issuance of shares and bonds at the EU stock exchange.